These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

345 related items for PubMed ID: 21059740

  • 1. n-3 polyunsaturated fatty acids for the prevention of arrhythmia recurrence after electrical cardioversion of chronic persistent atrial fibrillation: a randomized, double-blind, multicentre study.
    Bianconi L, Calò L, Mennuni M, Santini L, Morosetti P, Azzolini P, Barbato G, Biscione F, Romano P, Santini M.
    Europace; 2011 Feb; 13(2):174-81. PubMed ID: 21059740
    [Abstract] [Full Text] [Related]

  • 2. n-3 polyunsaturated fatty acids in the prevention of atrial fibrillation recurrences after electrical cardioversion: a prospective, randomized study.
    Nodari S, Triggiani M, Campia U, Manerba A, Milesi G, Cesana BM, Gheorghiade M, Dei Cas L.
    Circulation; 2011 Sep 06; 124(10):1100-6. PubMed ID: 21844082
    [Abstract] [Full Text] [Related]

  • 3. Prevention of atrial fibrillation after cardioversion: results of the PAFAC trial.
    Fetsch T, Bauer P, Engberding R, Koch HP, Lukl J, Meinertz T, Oeff M, Seipel L, Trappe HJ, Treese N, Breithardt G, Prevention of Atrial Fibrillation after Cardioversion Investigators.
    Eur Heart J; 2004 Aug 06; 25(16):1385-94. PubMed ID: 15302102
    [Abstract] [Full Text] [Related]

  • 4. N-3 polyunsaturated fatty acids administration does not reduce the recurrence rates of atrial fibrillation and inflammation after electrical cardioversion: a prospective randomized study.
    Ozaydın M, Erdoğan D, Tayyar S, Uysal BA, Doğan A, Içli A, Ozkan E, Varol E, Türker Y, Arslan A.
    Anadolu Kardiyol Derg; 2011 Jun 06; 11(4):305-9. PubMed ID: 21543294
    [Abstract] [Full Text] [Related]

  • 5. The effect of oral magnesium, alone or as an adjuvant to sotalol, after cardioversion in patients with persistent atrial fibrillation.
    Frick M, Darpö B, Ostergren J, Rosenqvist M.
    Eur Heart J; 2000 Jul 06; 21(14):1177-85. PubMed ID: 10924301
    [Abstract] [Full Text] [Related]

  • 6. Rhythm control versus rate control in patients with persistent atrial fibrillation. Results of the HOT CAFE Polish Study.
    Opolski G, Torbicki A, Kosior D, Szulc M, Zawadzka M, Pierścińska M, Kołodziej P, Stopiński M, Wozakowska-Kapłon B, Achremczyk P, Rabczenko D.
    Kardiol Pol; 2003 Jul 06; 59(7):1-16; discussion 15-16. PubMed ID: 14560344
    [Abstract] [Full Text] [Related]

  • 7. Long-term omega-3 polyunsaturated fatty acid supplementation reduces the recurrence of persistent atrial fibrillation after electrical cardioversion.
    Kumar S, Sutherland F, Morton JB, Lee G, Morgan J, Wong J, Eccleston DE, Voukelatos J, Garg ML, Sparks PB.
    Heart Rhythm; 2012 Apr 06; 9(4):483-91. PubMed ID: 22120130
    [Abstract] [Full Text] [Related]

  • 8. Oral amiodarone increases the efficacy of direct-current cardioversion in restoration of sinus rhythm in patients with chronic atrial fibrillation.
    Capucci A, Villani GQ, Aschieri D, Rosi A, Piepoli MF.
    Eur Heart J; 2000 Jan 06; 21(1):66-73. PubMed ID: 10610746
    [Abstract] [Full Text] [Related]

  • 9. Effects of sinus rhythm restoration in patients with persistent atrial fibrillation: a clinical, echocardiographic and hormonal study.
    Wozakowska-Kapłon B, Opolski G.
    Int J Cardiol; 2004 Aug 06; 96(2):171-6. PubMed ID: 15262030
    [Abstract] [Full Text] [Related]

  • 10. Maintenance of sinus rhythm with metoprolol CR initiated before cardioversion and repeated cardioversion of atrial fibrillation: a randomized double-blind placebo-controlled study.
    Nergårdh AK, Rosenqvist M, Nordlander R, Frick M.
    Eur Heart J; 2007 Jun 06; 28(11):1351-7. PubMed ID: 17329409
    [Abstract] [Full Text] [Related]

  • 11. Atorvastatin given prior to electrical cardioversion does not affect the recurrence of atrial fibrillation in patients with persistent atrial fibrillation who are on antiarrhythmic therapy.
    Demir K, Can I, Koc F, Vatankulu MA, Ayhan S, Akilli H, Aribas A, Alihanoglu Y, Altunkeser BB.
    Med Princ Pract; 2011 Jun 06; 20(5):464-9. PubMed ID: 21757938
    [Abstract] [Full Text] [Related]

  • 12. Electrical cardioversion for persistent atrial fibrillation or atrial flutter in clinical practice: predictors of long-term outcome.
    Boriani G, Diemberger I, Biffi M, Domenichini G, Martignani C, Valzania C, Branzi A.
    Int J Clin Pract; 2007 May 06; 61(5):748-56. PubMed ID: 17493088
    [Abstract] [Full Text] [Related]

  • 13. A randomized, placebo-controlled study of vernakalant (oral) for the prevention of atrial fibrillation recurrence after cardioversion.
    Torp-Pedersen C, Raev DH, Dickinson G, Butterfield NN, Mangal B, Beatch GN.
    Circ Arrhythm Electrophysiol; 2011 Oct 06; 4(5):637-43. PubMed ID: 21841207
    [Abstract] [Full Text] [Related]

  • 14. Atorvastatin and persistent atrial fibrillation following cardioversion: a randomized placebo-controlled multicentre study.
    Almroth H, Höglund N, Boman K, Englund A, Jensen S, Kjellman B, Tornvall P, Rosenqvist M.
    Eur Heart J; 2009 Apr 06; 30(7):827-33. PubMed ID: 19202157
    [Abstract] [Full Text] [Related]

  • 15. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F.
    Ann Cardiol Angeiol (Paris); 1996 Oct 06; 45(8):469-79. PubMed ID: 8952741
    [Abstract] [Full Text] [Related]

  • 16. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial.
    Saravanan P, Bridgewater B, West AL, O'Neill SC, Calder PC, Davidson NC.
    Circ Arrhythm Electrophysiol; 2010 Feb 06; 3(1):46-53. PubMed ID: 20042769
    [Abstract] [Full Text] [Related]

  • 17. Targeted pharmacological reversal of electrical remodeling after cardioversion--rationale and design of the Flecainide Short-Long (Flec-SL) trial.
    Kirchhof P, Fetsch T, Hanrath P, Meinertz T, Steinbeck G, Lehmacher W, Breithardt G.
    Am Heart J; 2005 Nov 06; 150(5):899. PubMed ID: 16290956
    [Abstract] [Full Text] [Related]

  • 18. Statins and amiodarone improve freedom from recurrence of atrial fibrillation after successful cardioversion.
    Naji F, Suran D, Kanic V, Vokac D, Sabovic M.
    Med Sci Monit; 2009 Sep 06; 15(9):CR494-8. PubMed ID: 19721402
    [Abstract] [Full Text] [Related]

  • 19. Noninvasive time and frequency predictors of long-standing atrial fibrillation early recurrence after electrical cardioversion.
    Alcaraz R, Hornero F, Rieta JJ.
    Pacing Clin Electrophysiol; 2011 Oct 06; 34(10):1241-50. PubMed ID: 21605132
    [Abstract] [Full Text] [Related]

  • 20. Omega-3 fatty acids for the prevention of recurrent symptomatic atrial fibrillation: results of the FORWARD (Randomized Trial to Assess Efficacy of PUFA for the Maintenance of Sinus Rhythm in Persistent Atrial Fibrillation) trial.
    Macchia A, Grancelli H, Varini S, Nul D, Laffaye N, Mariani J, Ferrante D, Badra R, Figal J, Ramos S, Tognoni G, Doval HC, GESICA Investigators.
    J Am Coll Cardiol; 2013 Jan 29; 61(4):463-468. PubMed ID: 23265344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.